I very much appreciate your intelligent post, as it allows

New Post Public Reply Private Reply Replies (2) Message Board
craigakess gestalt2 #114343
576
I very much appreciate your intelligent post, as it allows us to show where we differ on some things. In the end, we ALL want CYDY and leronlimab to be successful, it's just a matter of how we get there.

I don't think that the run-up from $1 to $10 was simply a pump and dump as you put it. Nader IS responsible when he makes comments about how well something is going or when something will get done and how good it looks, and investors act on it. He IS the only source of information and thus should understand that responsibility.

You are correct, Nader is running the company the same way at $.30 as at any other price, and that is to say he pumps it like a smiling buffoon, waving 3 fingers, and he cannot figure out how to get 50 people in a trial in Brazil that has tens of thousands of sick people. Still over-promising and under-delivering as usual.

No third party is failing to see what leronlimab may be worth, but they ARE seeing what it is worth in the hands of someone who has failed to deliver on the drug's promise time and time again. Is that really not clear by now? I AGREE with you and would be pissed to sell for $1-2, however NP has not proven he can create value for the past 3 years at least. Now, $2 is almost 3x the current SP. So sad!

OF COURSE NP is well aware of the current share price and without a doubt, this "challenge" could have been avoided if he had assembled more of a team that knew what it was doing and could help him as he is not skilled in these areas. That is a failure of leadership. It would be a challenge for me to represent someone in a capital murder case, because that is not what I do, not what I have any experience doing. But I could make myself more proficient and also employ people who could help me to do a better job. Yes, maybe Recknor is that guy, but is it too little too late? The money is running out and we have zero leverage now. Time is not on our side.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Classic vs. Youngtimer Cars: Evolution in Collecting

Updated Category News Views 90

The Collector's Journey: Classic Cars vs. Youngtimers Ever notice how car collecting has its own circles of fame? You're either basking in the glow of a vintage classic or eyeing a youngtimer that’s just catching steam. In this article from HelloNation, Engels Gualdani — the classic car sage of Hilton, NY — helps untangle these categories for us, and it’s a lesson...

Continue Reading
Smart Banner Choices: Decisions Beyond Design

Updated Category News Views 152

Location, Location, Location: Banner Insights Picking a banner isn't just a quick snap decision. You got to think big, and location is a starting line. Adam Norsworthy from Minuteman Press underscores that understanding how and where this piece of publicity will hang matters more than you might guess. Outdoor or indoor isn't just a weather question; it's a matter of...

Continue Reading
PangeAI and Sky Blue Transform Data Center Decisions

Updated Category News Views 80

Just when you thought the incessant trials of picking a prime data center site couldn’t get any more grueling or expensive, enter PangeAI and its brand-new ally, Sky Blue Impact. These tech firms have partnered up to speed up what has traditionally been a sluggish, pricey process. Here’s the deal: PangeAI’s geospatial AI platform lets Sky Blue dodge the usually...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 37

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
Toys"R"Us Rolls Out 160 U.S. Stores, NYC Celebration

Updated Category News Views 146

Rebuilding the Toy Empire After a rough few years, Toys"R"Us is clawing its way back into the hearts—and wallets—of American shoppers. With 160+ new standalone stores popping up like mushrooms after rain, these guys aren't just playing games. This is a strategic move to reestablish their presence in the retail landscape just before the holiday shopping frenzy kicks...

Continue Reading
Nagarro's Earnings Show Stagnant Growth Amid Flat Margins

Updated Category News Views 96

Nagarro's Financial Picture: A Glimpse Live a day in the trading pits and you'll learn to spot when a company is merely treading water. That's the vibe I'm getting from Nagarro's Q3 2026 results. They might label themselves as an AI-native leviathan, but these numbers spell out a story of struggle wrapped in fancy buzzwords. Revenue Uptick or Revenue Hiccup? For the nine...

Continue Reading
APEC Summit 2026: Shenzhen in the Spotlight

Updated Category News Views 58

An International Stage for Shenzhen Alright, folks, here's the deal. We’ve got the 2026 APEC Summit rolling into Shenzhen, perched right there in Guangdong Province, and the world’s eyes are glued to it. Happens November 18–19, and you better believe it’s a magnet for all things global. The China Media Group’s Chinese Global Program Center isn’t missing a...

Continue Reading
Endava Faces Class Action: Investor Reactions and Next Steps

Updated Category News Views 72

Trouble at Endava: Leadership Shakeup and Financial Concerns So, here's the kicker—Endava's got itself into one mighty mess worth chewing over with your morning coffee. When your top brass drops like flies, and you're fumbling your financials, investors start sweating bullets. On October 28, 2026, Endava plc (NYSE: DAVA) confesses to some serious accounting missteps....

Continue Reading
First Horizon's $25M Bet: New Center Transforms Houston

Updated Category News Views 76

New Markets Tax Credits: A Game Changer First things first, if you're thinking this is some typical charitable write-off, think again. First Horizon Bank (NYSE: FHN) is deep in the mix of something pretty transformative in the world of finance and community support. They're not just throwing money at a problem and hoping it sticks. Nope, we're talking real strategy with a...

Continue Reading
Perpetua Reports Q3 2026 Results, Progress on Project

Updated Category News Views 58

A Steady Climb for Perpetua Resources It's like watching a boxer steadily climb the ranks, waiting for the big title fight. That's the scene with Perpetua Resources (NASDAQ:PPTA) as their Q3 2026 financial results hit the wires. No confetti cannons this time, just solid, gritty steps towards a promising future. Q3 Financial Results: A Prudent Path The financials for...

Continue Reading

Top 5 Most Recently Viewed Articles

Strengthening Heart and Kidney Health Through Collaboration

Updated Category News Views 264

Collaboration for Health Awareness In an exciting development, the American Kidney Fund (AKF) has forged a partnership with the American Heart Association (AHA) as part of their Cardiovascular-Kidney-Metabolic Health Initiative™. This collaboration aims to raise awareness regarding the crucial link between kidney disease and cardiovascular conditions, both of which...

Continue Reading
Kering Faces Challenges Amid Analyst Downgrades and Market Slowdown

Updated Category News Views 106

Kering Faces Challenges Amid Analyst Downgrades and Market Slowdown Kering (EPA: PRTP) has recently experienced a shift in market sentiment as analysts express increasing caution regarding its performance. TD Cowen has notably lowered its price target for Kering to €230 from €260, while sustaining a Hold rating for the stock. The adjustment signals growing concerns...

Continue Reading
Xi Jinping Champions Common Development at G20 Summit

Updated Category News Views 308

Xi Jinping's Vision for Global Cooperation at the G20 Summit Chinese President Xi Jinping recently made headlines during a significant gathering known as the G20 Summit. His participation underscored a strong commitment to fostering global cooperation and development, marking a notable moment in international relations. Advocating for a Unified Approach During his...

Continue Reading
OHA Secures Financing for Onex's Acquisition of Farsound

Updated Category News Views 84

OHA Leads Innovative Financing for Strategic Acquisition In a significant development in the financial world, Oak Hill Advisors (OHA) has taken on the role of Lead Left Arranger for a private unitranche financing aimed at supporting the acquisition of Farsound Aviation Limited by Onex. Farsound stands out in the aerospace engine maintenance, repair, and overhaul (MRO)...

Continue Reading
Zentalis Pharmaceuticals Rebounds After FDA Clearance for Azenosertib

Updated Category News Views 75

Zentalis Pharmaceuticals Advances with Azenosertib Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL), located in San Diego, has some exciting updates for its stakeholders. The U.S. Food and Drug Administration (FDA) has lifted the partial clinical hold on the company's studies involving azenosertib. This is fantastic news, as it enables Zentalis to restart patient enrollment...

Continue Reading